Epithelix Sàrl
Innovative in vitro respiratory solutions
Epithelix Sàrl provides alternative in vitro solutions to animal experimentation for evaluating the effects of drugs in development and assess the toxicity of chemical compounds on the human respiratory tract.
The company is the European leading provider of in vitro reconstituted human respiratory tissues and related services to leading academic research laboratories. Epithelix also supplies and supports Personal Care, Medical Device, as well as Chemical and Pharmaceutical.
Only registered users have access to funding information.
Please log in or register to continue. Registration is free.
04.02.2025
FIT backs Five Ventures from CHUV, EPFL and HEIG-VD (startupticker.ch)
Last Tweets
No milestones
No Jobs
Documents
TOP 100 Swiss Startup Award
The TOP 100 Swiss Startup Ranking features the 100 most promising startups that are not older than five years and are selected by a jury of early-stage investors.
Venture Leaders Technology
The Venture Leaders - the members of the Swiss national startup team- have a clear-cut goal. They envision themselves as global players and want to take the first step to their global expansion. The ten-day business development program is specifically structured to help them achieve this goal.
>>Venture>>
The venture business plan competition takes place every year and combines a competition, learning events and contact form in one. It is an initiative of the ETH Zurich, CTI and McKinsey.
CTI Start-up Label
CTI Start-up enables entrepreneurs to realize their innovative idea professionally.
In a process of three phases, over forty experienced coaches guide start-up companies on their way to enter the market successfully and attract financing. At the end of the coaching process, the most promising start-up companies have the opportunity to receive the prestigious CTI Start-up ’Label’. In addition, the companies benefit from the wide CTI Start-up network of industry experts, experienced entrepreneurs, business angels, venture capitalists and has access to foundations such as de Vigier, STI, FIT, Gebert, Rüf, etc.
Until today, CTI Start-up reviewed more than 1 800 projects, and awarded over 200 start-up enterprises with the CTI Start-up Label. Over 85% of these companies are still in business and some have shown remarkable growth, which is a sign that CTI Start-up guides them to sustainable success.
CTI also promotes the culture of entrepreneurship at universities, teaching hospitals, technical institutes as well as universities of applied sciences. CTI Entrepreneurship offers workshops to students on how to bring innovation to the market.
Fondation Liechti: Prix "Coup de pouce" et "Coup de coeur"
La bourse annuelle est destinée à soutenir un projet d'entreprise qui présente des aspects économiques définis, et de préférence des effets humanitaires. Ce projet doit donc générer un progrès durable dans des domaines tels que la santé, l'éthique, la lutte contre la pauvreté ou pour l'environnement. Une utilité générale et une portée universelle représentent des atouts décisifs. La bourse annuelle est d'un montant unique de CHF 50'000 (Coup de pouce) et CHF 30'000 (Coup de coeur) qui peut être distribué en deux échéances.
Epithelix Sàrl
Innovative in vitro respiratory solutions
Website:
www.epithelix.com
Headquarter:
Plan-les-Ouates
Foundation Date:
March 2006
Technology:
- Biotech
Sectors:
- Biomaterials
Support received
